FAMILY DOCTOR WANNABE
  • Home
  • About
  • Blog
  • Learn Medicine
  • Contact

I'll be back. Currently meditating...

Priority Topic: Atrial Fibrillation

6/10/2018

0 Comments

 
Key Feature 3a: In an individual presenting with chronic or paroxysmal atrial fibrillation: Explore the need for anticoagulation based on the risk of stroke with the patient.
Skill: Patient Centered, Clinical Reasoning
Phase: Diagnosis, Treatment

Key Feature 3b: In an individual presenting with chronic or paroxysmal atrial fibrillation: Periodically reassess the need for anticoagulation.
Skill: Clinical Reasoning
Phase: Hypothesis generation, Follow-up

Key Feature 4: In patients with atrial fibrillation, when the decision has been made to use anticoagulation, institute the appropriate therapy and patient education, with a comprehensive follow-up plan.
Skill: Clinical Reasoning
Phase: Treatment, Follow-up

Key Feature 5: In a stable patient with atrial fibrillation, identify the need for rate control.
Skill: Clinical Reasoning
Phase: Hypothesis generation, Treatment

Key Feature 6: In a stable patient with atrial fibrillation, arrange for rhythm correction when appropriate.
Skill: Clinical Reasoning, Selectivity
Phase: Hypothesis generation, Treatment

In a patient with atrial fibrillation, whether or not they should be anticoagulated is based on the risk for stroke versus having a serious bleed. The CHADS2-VASc risk stratification score is the standard assessment tool to assess for the risk of stroke, while the HAS-BLED risk stratifications score is the equivalent to asses for the risk of a major bleed. In realtime, I use a medical calculator app (Canadian Cardiovascular Society) to determine the risk scores for the patient in front of me to help me make a decision. It's important to have a patient-centered conversation. Although the chances of having a major bleed may be higher for the patient than the risk of stroke based on their risk stratification scores, the majority of such patients may prefer to be anticoagulated given the proportional risk for decrease in quality of life should one versus the other occur. It is important to periodically reassess the need for anticoagulation as a patient's risk of stroke, risk of sustaining a major bleed, and goals of care may change over time. 
The Canadian Cardiovascular Society Atrial Fibrillation Guideline recommends the following for prevention of stroke and systemic embolism:
  • Recommendation 1: Stratification of patients using a predictive index for stroke risk
  • Recommendation 2: Oral anticoagulant therapy (OAC) for patients ≥ 65 years or CHADS2-VASc ≥ 1
  • Recommendation 3: Acetylsalicylic acid (ASA) for patients with no risks besides arterial vascular disease
  • Recommendation 4: No antithrombotic therapy for patients with no major risks​
  • Recommendation 5: Most patients should receive non-vitamin K oral anticoagulant therapy (NOAC)
  • Recommendation 6: Warfarin when mechanical valve, mitral stenosis, or renal dysfunction (15-30 mL/min)
  • Recommendation 7: Patients who refuse OAC should receive ASA pus clopidogrel
  • Recommendation 8: OAC therapy for highly selected patients with subclinical atrial fibrillation (AF)
  • Recommendation 9: OAC for 3 weeks before and at least 4 weeks post cardioversion
  • Recommendation 10: Annual renal function assessment
  • Recommendation 11: Antithrombotic therapy should relate to creatinine clearance (CrCl)
  • Recommendation 12: Left atrial appendage closure devices to be used only in research and exceptional cases
  • Recommendation 13: Acute management of stroke patients as per American Heart Association (AHA)/American Stroke Association (ASA) guidelines (i.e., ACLS)
  • Recommendation 14: Hemorrhage on OAC to be managed per American College of Chest Physicians (AACP) guidelines 
  • Recommendation 15: Idarucizimab for emergency reversal of dabigatran's anticoagulant effect

In follow-up care of a patient who has been diagnosed with atrial fibrillation, be it paroxysmal, persistent, or permanent, the following issues should be reviewed:
  1. Symptoms and functional status
  2. Review of management for stroke risk
  3. Review of management for either rhythm or rate control (see below)
  4. Routine investigations may include repeat ECG and bloodwork to reassess kidney and liver functioning
The Canadian Cardiovascular Society Atrial Fibrillation Guideline recommends the following for rate control of Atrial Fibrillation:
  1. ​Recommendation 1: Goals of rate control therapy should be to improve symptoms and clinical outcomes which are attributable to excessive ventricular rates
  2. Recommendation 2: Ventricular rate should be assessed in all patients at rest
  3. Recommendation 3: Heart rate (HR) during exercise should be assessed, along with associated exertional symptoms
  4. Recommendation 4: Aim for a resting HR < 100 bpm
  5. Recommendation 5: Beta-blockers or nondihydropyridine calcium channel blockers (CCB) as initial therapy
  6. Recommendation 6: Digoxin rate control: selected sedentary and left ventricular (LV) systolic dysfunction patients
  7. Recommendation 7: Digoxin added when other therapies fail
  8. Recommendation 8: Amiodarone for rate control therapy in exceptional cases
  9. Recommendation 9: Dronedarone, not for patients with permanent AF
  10. Recommendation 10: Dronedarone, not for patients with history of heart failure (HF)
  11. Recommendation 11: Dronedarone, to be used with caution with patients taking digoxin
  12. Recommendation 12: Beta-blockers as initial therapy in patients with MI or LV systolic dysfunction
  13. Recommendation 13: Atrial ventricular node (AVN) ablation pacemaker in symptomatic drug-refractory patients

The Canadian Cardiovascular Society Atrial Fibrillation Guideline recommends the following for rate control of Atrial Fibrillation:
  1. Recommendation 1: Treat precipitating or reversible conditions
  2. Recommendation 2: Rhythm control strategy for patents symptomatic on rate control therapy
  3. Recommendation 3: Goal of rhythm control therapy should be improvement in patient symptoms and clinical outcomes, and not necessarily the elimination of all AF
  4. Recommendation 4: Maintenance antiarrhythmic drugs first-line in patients with recurrent AF
  5. Recommendation 5: Avoid antiarrhythmic in patients with advanced sinus or AV node disease
  6. Recommendation 6: AV blocking agent to be used along with a class I antiarrhythmic drug
  7. Recommendation 7: 'Pill in the pocket' therapy in patients with infrequent AF
  8. Recommendation 8: Electrical or pharmacological cardioversion for sinus rhythm restoration
  9. Recommendation 9: Pretreatment with antiarrhythmic drugs before electrical cardioversion
  10. Recommendation 10: For symptomatic bradycardia, dual-chamber pacing
  11. Recommendation 11: Pacemaker to be programmed to minimize ventricular pacing
0 Comments



Leave a Reply.

    RSS Feed

    Categories

    All
    Abdominal Pain
    Addiction Medicine
    Advanced Cardiac Life Support
    Allergy
    Anemia
    Antibiotics
    Anxiety
    Asthma
    Atrial Fibrillation
    Bad News
    Behavioural Medicine & Resident Wellness
    Behavioural Problems
    Breast Lump
    Cancer
    Care Of Children + Adolescents
    Care Of Men
    Care Of The Elderly
    Chest Pain
    Chronic Disease
    Chronic Obstructive Pulmonary Disease
    Collaborator
    Communicator
    Contraception
    Cough
    Counselling
    Crisis
    Croup
    Dehydration
    Dementia
    Depression
    Diabetes
    Diarrhea
    Difficult Patient
    Disability
    Dizziness
    Domestic Violence
    Dysuria
    Earache
    Eating Disorders
    Elderly
    Family Medicine
    Fatigue
    Fever
    Fractures
    Gender Specific Issues
    Genitourinary & Women's Health
    Grief
    Health Advocate
    HIV Primary Care
    Hypertension
    Immigrants
    Immunization
    In Children
    Infections
    Infertility
    Injections & Cannulations
    Insomnia
    Integumentary
    Ischemic Heart Disease
    Lacerations
    Learning (Patients)
    Learning (Self Learning)
    Manager
    Maternity Care
    Meningitis
    Menopause
    Mental Competency
    Mental Health
    Multiple Medical Problems
    Newborn
    Obesity
    Obstetrics
    Osteoporosis
    Palliative Care
    Periodic Health Assessment/Screening
    Personality Disorder
    Pneumonia
    Poisoning
    Pregnancy
    Priority Topic
    Procedures
    Professional
    Prostate
    Rape/Sexual Assault
    Red Eye
    Resuscitation
    Schizophrenia
    Sex
    Sexually Transmitted Infections
    Smoking Cessation
    Somatization
    Stress
    Substance Abuse
    Suicide
    Surgical + Procedural Skills
    Transition To Practice
    Trauma
    Urinary Tract Infection
    Vaginal Bleeding
    Vaginitis
    Violent/Aggressive Patient
    Well Baby Care
    Well-baby Care
    Women's Health

Proudly powered by Weebly
  • Home
  • About
  • Blog
  • Learn Medicine
  • Contact